GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » CLSA Premium Ltd (HKSE:06877) » Definitions » Valuation Rank

CLSA Premium (HKSE:06877) Valuation Rank


View and export this data going back to 2013. Start your Free Trial

What is CLSA Premium Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


CLSA Premium Valuation Rank Related Terms

Thank you for viewing the detailed overview of CLSA Premium's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


CLSA Premium Business Description

Traded in Other Exchanges
N/A
Address
88 Queensway, Suite 804, Level 8, One Pacific Place, Hong Kong, HKG
CLSA Premium Ltd operates in the financial services sector. It provides leveraged forex and other trading, cash dealing, sales of healthcare products and other services.. The operating segments of the group are the Margin dealing segment. Unallocated segment, Healthcare products segment, The margin dealing segment is engaged in the provision of leveraged foreign exchange, commodity and index trading services in Australia, Hong Kong and New Zealand. The healthcare products segment engages in the sales of healthcare products. It has a business presence in Hong Kong, Australia, New Zealand and Other countries.
Executives
Beijing Tong Ren Tang (cayman) Limited 2101 Beneficial owner
Top Eminent Invest Co., Ltd. 2201 Interest of corporation controlled by you
Ji Guangfei 2201 Interest of corporation controlled by you
Citic Securities Company Limited 2201 Interest of corporation controlled by you
Calypso International Investment Co., Limited 2101 Beneficial owner
Ci Hang Dong Xi Fang Wen Jiao Jiao Liu Ji Jin Hui You Xian Gong Si 2201 Interest of corporation controlled by you
Hai Hang Su Yun Tou Zi Shang Hai You Xian Gong Si 2201 Interest of corporation controlled by you
Hai Nan Sheng Ci Hang Gong Yi Ji Jin Hui 2201 Interest of corporation controlled by you